Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/117170
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Bioque Alcázar, Miquel |
dc.contributor.author | Llerena, Adrián |
dc.contributor.author | Cabrera, Bibiana |
dc.contributor.author | Mezquida, Gisela |
dc.contributor.author | Lobo, Antonio |
dc.contributor.author | González-Pinto, Ana |
dc.contributor.author | Díaz-Caneja, Covadonga M. |
dc.contributor.author | Corripio, Iluminada |
dc.contributor.author | Aguilar, Eduardo J. |
dc.contributor.author | Bulbena Vilarrasa, Antonio |
dc.contributor.author | Castro Fornieles, Josefina |
dc.contributor.author | Vieta i Pascual, Eduard, 1963- |
dc.contributor.author | Lafuente, Amàlia, 1952- |
dc.contributor.author | Mas Herrero, Sergi |
dc.contributor.author | Parellada, Mara |
dc.contributor.author | Sáiz Ruiz, Jerónimo |
dc.contributor.author | Cuesta, Manuel J. |
dc.contributor.author | Bernardo Arroyo, Miquel |
dc.contributor.author | PEPs GROUP |
dc.contributor.author | Contreras, Fernando |
dc.contributor.author | Gassó Astorga, Patricia |
dc.date | 2017-10-27T10:29:46Z |
dc.date | 2017-10-27T10:29:46Z |
dc.date | 2016-03 |
dc.date | 2017-10-27T10:29:46Z |
dc.identifier.citation | 1461-1457 |
dc.identifier.citation | 655174 |
dc.identifier.uri | http://hdl.handle.net/2445/117170 |
dc.format | 10 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Oxford University Press |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1093/ijnp/pyv121 |
dc.relation | International Journal of Neuropsychopharmacology, 2016, vol. 19, num. 4, p. 1-10 |
dc.relation | https://doi.org/10.1093/ijnp/pyv121 |
dc.rights | cc-by-nc (c) Bioque Alcázar, Miquel et al., 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by-nc/3.0/es |
dc.subject | Farmacoepidemiologia |
dc.subject | Farmacovigilància |
dc.subject | Psicosi |
dc.subject | Farmacologia |
dc.subject | Antipsicòtics |
dc.subject | Psicofàrmacs |
dc.subject | Espanya |
dc.subject | Seguretat dels pacients |
dc.subject | Pharmacoepidemiology |
dc.subject | Drug monitoring |
dc.subject | Psychoses |
dc.subject | Pharmacology |
dc.subject | Antipsychotic drugs |
dc.subject | Psychotropic drugs |
dc.subject | Spain |
dc.subject | Patients safety |
dc.title | A pharmacovigilance study in first episode of psychosis: Psychopharmacological interventions and safety profiles in the PEPs Project |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |